# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-027931
Filing Date
2022-11-03
Accepted
2022-11-03 06:09:12
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | auph-20220930.htm iXBRL | 10-Q | 1276757
2 | EX-10.24 | exhibit1024separationagree.htm | EX-10.24 | 69057
3 | EX-10.25 | exhibit1025separationagree.htm | EX-10.25 | 51125
4 | EX-10.26 | exhibit1026separationagree.htm | EX-10.26 | 51461
5 | EX-31.1 | auph-2022q3exx311.htm | EX-31.1 | 10973
6 | EX-31.2 | auph-2022q3exx312.htm | EX-31.2 | 11115
7 | EX-32.1 | auph-2022q3exx321.htm | EX-32.1 | 5445
8 | EX-32.2 | auph-2022q3exx322.htm | EX-32.2 | 5453
14 |  | image_0.jpg | GRAPHIC | 8863
15 |  | image_01.jpg | GRAPHIC | 8863
| Complete submission text file | 0001628280-22-027931.txt |  | 6517192

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | auph-20220930.xsd | EX-101.SCH | 40668
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | auph-20220930_cal.xml | EX-101.CAL | 65101
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | auph-20220930_def.xml | EX-101.DEF | 186402
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | auph-20220930_lab.xml | EX-101.LAB | 524623
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | auph-20220930_pre.xml | EX-101.PRE | 349403
77 | EXTRACTED XBRL INSTANCE DOCUMENT | auph-20220930_htm.xml | XML | 1088079

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 221355999
SIC: 2834 Pharmaceutical Preparations